๐Ÿ“– Complete Guideโœ… Updated 2026๐Ÿ”ฌ Evidence-Based

Tirzepatide Week-by-Week

Mounjaro & Zepbound Timeline

Week-by-week guide to Mounjaro and Zepbound. What to expect at each dose, typical weight loss timeline, and managing side effects.

Your Tirzepatide Journey

Tirzepatide works on both GLP-1 and GIP receptors, often producing faster results than semaglutide alone.

Mounjaro vs Zepbound

Same medication, different indication. Both are tirzepatide made by Eli Lilly. The only difference is FDA approval:

The timeline above applies to both. Insurance coverage may differ based on which is prescribed.

Mounjaro: Approved for Type 2 diabetes. Zepbound: Approved for chronic weight management.

Why Track This Protocol

๐Ÿ“Š

Evidence-Based

Tirzepatide Week by Week protocols are grounded in clinical research โ€” use Shotlee to track your own data against published outcomes.

๐Ÿ’‰

Dose Tracking

Log each dose with exact amount and timing. Consistent records reveal patterns that improve protocol optimization.

๐Ÿ”ฌ

Outcome Monitoring

Track weight, symptoms, and key metrics weekly. Objective data helps you and your provider make better decisions.

โš ๏ธ

Side Effect Log

Record any adverse reactions immediately. Early pattern detection prevents dose escalation issues before they worsen.

๐Ÿ”ฌ

Progress Charts

Shotlee visualizes your trend data over weeks and months โ€” see the full picture, not just today's snapshot.

๐Ÿ”ฌ

Protocol Adherence

Consistency is the strongest predictor of GLP-1 success. Track missed doses and stay accountable with Shotlee reminders.

Guide FAQs

Week-by-week guide to Mounjaro and Zepbound. What to expect at each dose, typical weight loss timeline, and managing side effects.

Yes. Shotlee supports tracking Tirzepatide Week By Week doses, side effects, and health metrics. It is free.

References

  1. [1]Clinical TrialJastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387:205-216.
  2. [2]Clinical TrialFrรญas JP et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2). N Engl J Med. 2021;385:503-515.
  3. [3]FDAEli Lilly. Mounjaro (tirzepatide) Prescribing Information. U.S. Food and Drug Administration.
  4. [4]FDAEli Lilly. Zepbound (tirzepatide) Prescribing Information. U.S. Food and Drug Administration.

Track Your Tirzepatide Week By Week Protocol in Shotlee

Free dose logging, side effect tracking, and health metric monitoring for your complete protocol.

๐Ÿš€ Use Shotlee for Free